Optic neuritis in crohn`s disease showing wernicke`s encephalopathy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김승현 | - |
dc.date.accessioned | 2021-08-04T05:39:04Z | - |
dc.date.available | 2021-08-04T05:39:04Z | - |
dc.date.issued | 20041007 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/74006 | - |
dc.description.abstract | Crohn`s disease is a common disorder of the gastointestinal tract that primarily affects the terminal ileum. The most common neurologic problem encountered is seizure disorder. but, optic neuritis in Crohn`s disease is rare. We reported a case of optic neuritis in Crohn`s disease showing Wernicke`s encephalopathy. Case : A 20-year-old man was diagnosed as Crohn`s disease by biopsy of appendix after appendectomy at 15 years old. He admitted to our hospital due to enterocutaneous fistula accompanied to Crohn`s disease. During hospital days, he complained of dizziness, gait disturbance and diplopia. In neurologic examination, ataxia and bilateral ophthalmoplegia was found. To rule out Wernickes`s encephalopathy, thiamine injection was tried. And, neurologic symptom was improved. At the similar time, blurred vision on right eye was encountered. And, visual acuity on right eye was decreased and optic neuritis was suspected. His visual acuity got worse over 3 days. But, the visual acuity was improved after steroid pulse therapy. | - |
dc.title | Optic neuritis in crohn`s disease showing wernicke`s encephalopathy | - |
dc.type | Conference | - |
dc.citation.conferenceName | 대한신경과학회추계학술대회 | - |
dc.citation.conferencePlace | 서울교육문화회관 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.